BioAlliance Pharma49 Bd Du General Martial Valin Paris, Paris 7501575015 Fax: 33-145580881 Phone: 33-145587600eMail:Website:https://www.bioalliancepharma.comLatest from BioAlliance PharmaOral CancerFrench firm brings candidiasis drug to U.S.By DrBicuspid.com staff writersBioAlliance Pharma has signed a licensing agreement with Vestiq Pharmaceuticals to commercialize its Oravig product in the U.S. for the treatment of oropharyngeal candidiasis in adults.September 23, 2012Oral CancerSosei brings oropharyngeal candidiasis treatment to JapanBy DrBicuspid.com staff writersSosei has acquired development and commercialization rights to Loramyc in Japan from BioAlliance Pharma. Loramyc is an antifungal agent administered as a mucoadhesive buccal tablet for treating oropharyngeal candidiasis in immunocompromised patients.May 15, 2011